Global Anticoagulant Reversal Drugs Market by Major Players, Product Type, by Application, and by Region (North America, Europe, China, Japan, South Korea, India)Forecast from 2020 to 2026

Published On: Jun 2020

Format: PDF

Publisher: Calibre Research

Pages: 91

Report ID: 14388

The Global Anticoagulant reversal drugs market size is valued at xx million USD in 2020 and it is likely to grow at xx million USD by the end of 2026, along with a CAGR of xx % during the forecast period from 2020 to 2026.

Overview: Global Anticoagulant Reversal Drugs

Anticoagulant reversal drugs are needed for the neutralization of anticoagulant treatment in the complicated situation of bleeding in heart attack or stroke. Andexxa is the only anticoagulant drug which is used for the reversal procedure for the impact of element Xa inhibitors.

It is mainly used when people are suffering from various difficulties from blood clots. The main objective of the initiative of anticoagulant Reversal drugs is to control the presence of Andexxa to numerous hospitals and patients to meet their larger requirements. This will ultimately help to gain the Andexxa sale in the hospital which increases the anticoagulant reversal drugs.

Dynamics: Global Anticoagulant Reversal Drugs Market

The increment in the prevalence of atrial fibrillation as well as cardiovascular disease is the attribute, which is expected to increase the global anticoagulant market. Thus, the gaining ageing population is expected to experience the instant growth of the anticoagulant reversal market. While, the acceptance of blockbuster drugs in coming years like Andexxa and a powerful pipeline are contributing to the growth of the Global anticoagulant reversal drugs market.

The governing authority initiative towards the healthcare investment, which helps to influence the worldwide anticoagulant reversal drugs market. However, the higher cost of patent medicines is one of the key restraints to the global anticoagulant reversal drugs market.

Global Anticoagulant Reversal Drugs: Vital Players

  • Pfizer
  • Bausch Health Companies
  • Fresenius
  • Boehringer Ingelheim
  • Amneal Pharmaceuticals
  • CSL Limited
  • Octapharma AG
  • Portola Pharmaceuticals
  • AMAG Pharmaceuticals

 

By Product Types:

 

  • Prothrombin Complex Concentrates (PCC)
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • Others

By Application:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

     

Regional Outlook: Global Anticoagulant Reversal Drugs Market

Geographically, North America is considered to be the biggest contributor in the global anticoagulant reversal drugs market owing to gained approvals as well as research and development by key pharmaceutical firms in the region. Europe also held major share in the global anticoagulant market applicable to product agreements. The increasing incidence of unmanageable bleeding episodes and utilization of anticoagulants will further drive the Anticoagulant Reversal Drugs market in North America and Europe.

The United States emerged as the biggest country-level industry because of efficient payment scenario for drugs, a higher cost of the currently approved drugs and accelerated drug acceptance released by American Food and Drug Administration (FDA) to drive the Global Anticoagulant Reversal Market. Whereas, the Asia Pacific region is all set to increase at the fastest rate during the predicted period.

By Regions:

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anticoagulant Reversal Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Anticoagulant Reversal Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Prothrombin Complex Concentrates (PCC)
1.4.3 Vitamin K
1.4.4 Protamine
1.4.5 Tranexamic Acid
1.4.6 Idarucizumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Anticoagulant Reversal Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Anticoagulant Reversal Drugs Market Perspective (2015-2026)
2.2 Anticoagulant Reversal Drugs Growth Trends by Regions
2.2.1 Anticoagulant Reversal Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anticoagulant Reversal Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Anticoagulant Reversal Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anticoagulant Reversal Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Anticoagulant Reversal Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Reversal Drugs Players by Market Size
3.1.1 Global Top Anticoagulant Reversal Drugs Players by Revenue (2015-2020)
3.1.2 Global Anticoagulant Reversal Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Anticoagulant Reversal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anticoagulant Reversal Drugs Market Concentration Ratio
3.2.1 Global Anticoagulant Reversal Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anticoagulant Reversal Drugs Revenue in 2019
3.3 Anticoagulant Reversal Drugs Key Players Head office and Area Served
3.4 Key Players Anticoagulant Reversal Drugs Product Solution and Service
3.5 Date of Enter into Anticoagulant Reversal Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Anticoagulant Reversal Drugs Historic Market Size by Type (2015-2020)
4.2 Global Anticoagulant Reversal Drugs Forecasted Market Size by Type (2021-2026)

5 Anticoagulant Reversal Drugs Breakdown Data by Application (2015-2026)
5.1 Global Anticoagulant Reversal Drugs Market Size by Application (2015-2020)
5.2 Global Anticoagulant Reversal Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Anticoagulant Reversal Drugs Market Size (2015-2020)
6.2 Anticoagulant Reversal Drugs Key Players in North America (2019-2020)
6.3 North America Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
6.4 North America Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

7 Europe
7.1 Europe Anticoagulant Reversal Drugs Market Size (2015-2020)
7.2 Anticoagulant Reversal Drugs Key Players in Europe (2019-2020)
7.3 Europe Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
7.4 Europe Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

8 China
8.1 China Anticoagulant Reversal Drugs Market Size (2015-2020)
8.2 Anticoagulant Reversal Drugs Key Players in China (2019-2020)
8.3 China Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
8.4 China Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

9 Japan
9.1 Japan Anticoagulant Reversal Drugs Market Size (2015-2020)
9.2 Anticoagulant Reversal Drugs Key Players in Japan (2019-2020)
9.3 Japan Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
9.4 Japan Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Anticoagulant Reversal Drugs Market Size (2015-2020)
10.2 Anticoagulant Reversal Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

11 India
11.1 India Anticoagulant Reversal Drugs Market Size (2015-2020)
11.2 Anticoagulant Reversal Drugs Key Players in India (2019-2020)
11.3 India Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
11.4 India Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Anticoagulant Reversal Drugs Market Size (2015-2020)
12.2 Anticoagulant Reversal Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Anticoagulant Reversal Drugs Market Size by Type (2015-2020)
12.4 Central & South America Anticoagulant Reversal Drugs Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Anticoagulant Reversal Drugs Introduction
13.1.4 Pfizer Revenue in Anticoagulant Reversal Drugs Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Bausch Health Companies
13.2.1 Bausch Health Companies Company Details
13.2.2 Bausch Health Companies Business Overview and Its Total Revenue
13.2.3 Bausch Health Companies Anticoagulant Reversal Drugs Introduction
13.2.4 Bausch Health Companies Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.2.5 Bausch Health Companies Recent Development
13.3 Fresenius
13.3.1 Fresenius Company Details
13.3.2 Fresenius Business Overview and Its Total Revenue
13.3.3 Fresenius Anticoagulant Reversal Drugs Introduction
13.3.4 Fresenius Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.3.5 Fresenius Recent Development
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Details
13.4.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.4.3 Boehringer Ingelheim Anticoagulant Reversal Drugs Introduction
13.4.4 Boehringer Ingelheim Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.4.5 Boehringer Ingelheim Recent Development
13.5 Amneal Pharmaceuticals
13.5.1 Amneal Pharmaceuticals Company Details
13.5.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Amneal Pharmaceuticals Anticoagulant Reversal Drugs Introduction
13.5.4 Amneal Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.5.5 Amneal Pharmaceuticals Recent Development
13.6 CSL Limited
13.6.1 CSL Limited Company Details
13.6.2 CSL Limited Business Overview and Its Total Revenue
13.6.3 CSL Limited Anticoagulant Reversal Drugs Introduction
13.6.4 CSL Limited Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.6.5 CSL Limited Recent Development
13.7 Octapharma AG
13.7.1 Octapharma AG Company Details
13.7.2 Octapharma AG Business Overview and Its Total Revenue
13.7.3 Octapharma AG Anticoagulant Reversal Drugs Introduction
13.7.4 Octapharma AG Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.7.5 Octapharma AG Recent Development
13.8 Portola Pharmaceuticals
13.8.1 Portola Pharmaceuticals Company Details
13.8.2 Portola Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drugs Introduction
13.8.4 Portola Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.8.5 Portola Pharmaceuticals Recent Development
13.9 AMAG Pharmaceuticals
13.9.1 AMAG Pharmaceuticals Company Details
13.9.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 AMAG Pharmaceuticals Anticoagulant Reversal Drugs Introduction
13.9.4 AMAG Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2015-2020)
13.9.5 AMAG Pharmaceuticals Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details